United States
Healthcare-focused private equity, lending and finance conference will explore ways to successfully close transactions and achieve growth.
Notwithstanding unfavorable changes to the Code, capital gain treatment is still available on the sale of patents in certain scenarios.
From funding to financing, venture capital activity through the third quarter of 2019 has been record breaking.
From contract research organizations to initial public offerings, life sciences finance leaders discuss issues in the bioscience businesses.
RSM senior industry analyst Adam Lohr shares the latest on deals, going public and more in the biotech, pharma and medical devices sectors.
What’s the secret to successful supply chain outsourcing in your life sciences business? Learn how technology can make the difference.
Syneos Health, a public company, shares its ASC 842 implementation journey and how RSM assisted with acting as an extension of their team.
Get yourself up to speed on the latest trends in private equity and mergers and acquisitions with the Q3 2019 HC and LS Industry Spotlight.
Pharmaceutical, biotech and medical device company finance leaders discuss ASC 842 lease accounting adoption complexities and challenges.
What can life sciences businesses do to ensure data protection, especially with their third parties? Get key cybersecurity considerations.
Get yourself up to speed on the latest trends in private equity and mergers and acquisitions with the Q2 2019 HC and LS Industry Spotlight.
Skepticism regarding artificial intelligence is understandable, but it’s often based on a misunderstanding of what AI really is.
RSM’s NetSuite experience and industry knowledge helped Apellis implement a comprehensive NetSuite solution in a short timeline.
How can life sciences companies looking to go public position themselves for success? It’s all about setting the stage early on.
Get yourself up to speed on the latest trends in private equity and mergers and acquisitions with the Q1 2019 HC and LS Industry Spotlight.
Patient support programs can become a risk to life sciences product manufacturers if used to gain preferential treatment for their products.
Wearable tech’s transformative power promotes healthy lifestyles, lowers insurance coverage spending and increases employee engagement.
Life sciences organizations are collecting customer data at an enormous rate leaving them vulnerable to cyberattacks.
Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2019.
Rhythm Pharmaceuticals discusses how RSM helped make a success with their recent implementation of a new ERP system.